Anteilseigner
Versant Venture Management LLC (14,55 %) NEA Management Co. LLC (12,58 %) Fidelity Management & Research Co. LLC (8,73 %) T. Rowe Price Associates, Inc. (Investment Management) (8,26 %) Baker Bros. Advisors LP (8,04 %) Avoro Capital Advisor LLC (7,42 %) BlackRock Fund Advisors (3,06 %) The Vanguard Group, Inc. (2,63 %) Aisling Capital Management LP (2,41 %) HBM Partners AG (Investment Management) (2,30 %) Citadel Advisors LLC (1,60 %) Geode Capital Management LLC (1,20 %) SSgA Funds Management, Inc. (1,01 %) Casdin Capital LLC (0,84 %) BlackRock Advisors LLC (0,54 %) Northern Trust Investments, Inc.(Investment Management) (0,47 %) ExodusPoint Capital Management LP (0,43 %) Charles Schwab Investment Management, Inc. (0,41 %)
Kontakt
Monte Rosa Therapeutics Inc.